Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.0200 (1.21%)
NASDAQ · Last Trade: Jan 17th, 10:12 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors